tradingkey.logo

Electromed Inc

ELMD
View Detailed Chart

24.850USD

+0.680+2.81%
Market hours ETQuotes delayed by 15 min
207.48MMarket Cap
27.53P/E TTM

Electromed Inc

24.850

+0.680+2.81%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.81%

5 Days

+5.07%

1 Month

+31.27%

6 Months

+0.28%

Year to Date

-15.91%

1 Year

+24.75%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
22 / 207
Overall Ranking
115 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
35.000
Target Price
+43.50%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.00M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 138.06.
Fairly Valued
The company’s latest PE is 28.75, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 6.15M shares, increasing 1.30% quarter-over-quarter.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Ticker SymbolELMD
CompanyElectromed Inc
CEOMr. James L. (Jim) Cunniff
Websitehttps://smartvest.com/
KeyAI